Myriad Operating Cycle from 2010 to 2026
| MYGN Stock | USD 5.12 0.02 0.39% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 83.35 | Current Value 87.52 | Quarterly Volatility 31.33071149 |
Check Myriad Genetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Myriad Genetics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 73.9 M, Total Revenue of 1 B or Gross Profit of 338.4 M, as well as many indicators such as Price To Sales Ratio of 1.62, Dividend Yield of 0.0665 or PTB Ratio of 1.94. Myriad financial statements analysis is a perfect complement when working with Myriad Genetics Valuation or Volatility modules.
Myriad | Operating Cycle | Build AI portfolio with Myriad Stock |
Evaluating Myriad Genetics's Operating Cycle across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Myriad Genetics's fundamental strength.
Latest Myriad Genetics' Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of Myriad Genetics over the last few years. It is Myriad Genetics' Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Myriad Genetics' overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
Myriad Operating Cycle Regression Statistics
| Arithmetic Mean | 101.49 | |
| Geometric Mean | 92.42 | |
| Coefficient Of Variation | 30.87 | |
| Mean Deviation | 23.39 | |
| Median | 106.42 | |
| Standard Deviation | 31.33 | |
| Sample Variance | 981.61 | |
| Range | 131 | |
| R-Value | 0.01 | |
| Mean Square Error | 1,047 | |
| R-Squared | 0.000067 | |
| Significance | 0.98 | |
| Slope | 0.05 | |
| Total Sum of Squares | 15,706 |
Myriad Operating Cycle History
About Myriad Genetics Financial Statements
Myriad Genetics investors utilize fundamental indicators, such as Operating Cycle, to predict how Myriad Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 83.35 | 87.52 |
Pair Trading with Myriad Genetics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Myriad Genetics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myriad Genetics will appreciate offsetting losses from the drop in the long position's value.Moving together with Myriad Stock
Moving against Myriad Stock
| 0.6 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.54 | ENGN | enGene Holdings Common | PairCorr |
| 0.34 | DSGN | Design Therapeutics | PairCorr |
| 0.34 | 63E | ONWARD MEDICAL BV | PairCorr |
The ability to find closely correlated positions to Myriad Genetics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Myriad Genetics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Myriad Genetics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Myriad Genetics to buy it.
The correlation of Myriad Genetics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Myriad Genetics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Myriad Genetics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Myriad Genetics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Myriad Genetics Correlation against competitors. To learn how to invest in Myriad Stock, please use our How to Invest in Myriad Genetics guide.You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Will Biotechnology sector continue expanding? Could Myriad diversify its offerings? Factors like these will boost the valuation of Myriad Genetics. Expected growth trajectory for Myriad significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Myriad Genetics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (4.35) | Revenue Per Share | Quarterly Revenue Growth (0.04) | Return On Assets | Return On Equity |
Investors evaluate Myriad Genetics using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Myriad Genetics' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Myriad Genetics' market price to deviate significantly from intrinsic value.
Understanding that Myriad Genetics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Myriad Genetics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Myriad Genetics' market price signifies the transaction level at which participants voluntarily complete trades.